Literature DB >> 30834342

Risk factors for delayed hemorrhage after colonoscopic postpolypectomy: Polyp size and operative modality.

Changqin Liu1, Ruijin Wu1, Xiaomin Sun1, Chunhua Tao1, Zhanju Liu1.   

Abstract

BACKGROUND AND AIM: Delayed postpolypectomy hemorrhage is relatively common, with occasional extensive blood loss, endangering life. This study aimed to determine the factors associated with postoperative hemorrhage.
METHODS: The study was a retrospective cohort study of patients hospitalized for colonoscopic polypectomy at the Department of Gastroenterology and Hepatology, Tenth People's Hospital of Tongji University, China, between January and December 2015. Data on gender, age, bowel preparation, location, size, number of polyps, operative modality, pathology, and operation practitioner were collected. Patients were divided into two groups based on the presence or absence of postoperative hemorrhage.
RESULTS: A total of 1962 polyps were detected in patients and they underwent polypectomy; hemorrhage occurred in 41 cases. A correlation was demonstrated between postpolypectomy hemorrhage and each of the following factors: polyp size and operative modality. The odds ratio (OR) was 4.535 (95% confidence interval [CI], 2.331-8.823) for 1-2-cm polyps, 4.008 (95% CI, 0.904-17.776) for 2-3-cm polyps, and 22.407 (95% CI, 5.783-86.812) for ≥3-cm polyps. Compared with argon plasma coagulation, OR was 9.128 (95% CI, 3.548-23.486) for endoscopic mucosal resection and 31.257 (95% CI, 7.009-139.395) for endoscopic submucosal dissection.
CONCLUSIONS: The independent risk factors for delayed postpolypectomy hemorrhage include polyp size and operative modality.

Entities:  

Keywords:  delayed postoperative hemorrhage; operative modality; polyp size; polypectomy

Year:  2018        PMID: 30834342      PMCID: PMC6386734          DOI: 10.1002/jgh3.12106

Source DB:  PubMed          Journal:  JGH Open        ISSN: 2397-9070


Introduction

The incidence of colorectal polyps is high in colonoscopy screening, accounting for 25% of lesions, mostly benign.1 Colorectal cancer is the third most common tumor worldwide and the fourth cause of morbidity from tumors.2 The early detection and removal of polyps lead to a marked reduction in the incidence of colorectal cancer.3, 4 Complications following polypectomy have significantly reduced with the advancement of the submucosal injection technique,5, 6, 7 but the potential for iatrogenic injury during polypectomy still exists.5 The primary complications are hemorrhage and perforation,8 and hemorrhage includes immediate and delayed postoperative bleeding. The incidence rate of the delayed type is 0.4–1.1%,9, 10 with evidently more blood loss compared with the immediate type and delayed management, endangering life. Hence, the prudence of clinicians should never be undermined.11 Therefore, the identification of risk factors for delayed postpolypectomy hemorrhage is essential for the reduction of risks of complications and bleeding. A spectrum of studies exists regarding postoperative hemorrhage, but with contradictory results. The relatively unequivocal awareness is the close correlation of polyp size with hemorrhage. More controversy of perceptions lies in the correlation with other factors, including polyp location, pathology, operative modality, concurrent diseases, and preoperative anticoagulation medications. Bowel preparation and surgeon experience are less referred. The causal factors for bleeding include concurrent lesions, bowel preparation, location and size of polyps, operative modality, and operation clinicians. This study analyzed the risk factors from the aforementioned multiple perspectives for delayed postpolypectomy hemorrhage.

Methods

This study was a retrospective cohort study analyzing patients who underwent colonoscopic polypectomy at the Department of Gastroenterology and Hepatology, Shanghai Tenth People's Hospital of Tongji University, China, between January and December 2015. Delayed hemorrhage was defined as more than one occurrence of overt bleeding per anus, including melena or hematochezia, 6 h after operation. Each delayed hemorrhage had undergone a therapeutic colonoscopy. The inclusion criteria were patients who underwent colonoscopic polypectomy at the age of 18–80 years, excluding patients with familial adenomatous polyps, polyps combined with inflammatory bowel disease, or a history of colorectal surgery. At least 1‐week cessation of anticoagulation medicines, such as aspirin, Plavix, and warfarin, was instructed for all patients, and not even one patient took the specific medicine at the interval of 1 week before operation. Bowel preparation was recorded by two doctors with more than 5 years of specific practice according to Ottawa Bowel Preparation Scale.12 Patient's information, including age, gender, concurrent diseases, bowel preparation, location, size and number of polyps, operative modality, pathology, and operation practitioner, was collected. Polyp size was assessed by an endoscopist and classified into four grades: <1 cm, 1–2 cm, 2–3 cm, and ≥3 cm. Polyp location was classified as rectum, left semicolon distal to the splenic flexure, and right semicolon proximal to the splenic flexure. Operative modalities comprised biopsy forceps polypectomy, argon plasma coagulation (APC), endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). Pathologically, polyps were divided into three types: hyperplastic and inflammatory polyps, adenomatous polyps (tubular adenoma, villous adenoma, and villous tubular adenoma), and serrated adenoma. Surgeons were classified into three grades based on practice experience: 5–10 years, 10–15 years, and more than 15 years. This retrospective study had been approved by the ethnic committee of Shanghai Tenth People's Hospital of Tongji University. All data were anonymized and deidentified.

Statistical analysis

All data were analyzed using SPSS version 21 (SPSS, Chicago, IL, USA). Enumeration data were expressed in percentage. Regarding measurement data, normal distribution was expressed in mean ± standard deviation, whereas nonnormal distribution was expressed in median (range). Continuous variables were statistically analyzed using the Student t test, and categorical variables were compared using the χ 2 test. The correlation was initially screened among all variables, followed by the binary logistic regression analysis of definitely correlated variables, and the odds ratio (OR) and 95% confidence interval (CI) were calculated for others after defining the first one as a reference value of 1. A double‐tailed P value <0.05 was considered statistically significant.

Results

Incidence rate of postpolypectomy hemorrhage

A total of 1962 polyps were detected in 709 patients; hemorrhage occurred in 41 cases, with an incidence rate of 5.8%. The bleeding interval was 1.85 ± 1.05 days after operation. Concurrent disease—diabetes, coronary heart disease, or cerebrovascular accident—was not correlated with delayed postpolypectomy hemorrhage, whereas hypertension patients were more susceptible to postoperative hemorrhage, as shown in Table 1.
Table 1

General information and complications of patients with delayed postpolypectomy hemorrhage.

Uneventful (n = 668)Hemorrhage (n = 41) P
Age (mean ± SD)61.00 ± 9.37662.71 ± 11.2370.263
Gender (%)0.044
Male435/668 (65.1)33/41 (80.0)
Female233/668 (34.9)8/41 (20.0)
Complications
High blood pressure285 (42.7)25 (61.0)0.022
Diabetes100 (15.0)4 (9.8)0.360
Coronary heart disease50 (7.5)5 (12.2)0.274
Cerebrovascular accident34 (5.1)2 (5)0.952
General information and complications of patients with delayed postpolypectomy hemorrhage.

Risk factors for delayed postpolypectomy hemorrhage

The risk factors for delayed postpolypectomy hemorrhage included polyp size and operative modality. No obvious correlation of delayed postpolypectomy hemorrhage was found with the pathological type, polyp location, bowel preparation, or operative experience. OR was 4.535 (95% CI, 2.331–8.823; P < 0.001) for 1–2‐cm polyps, 4.008 (95% CI, 0.904–17.776; P = 0.068) for 2–3‐cm polyps, and 22.407 (95% CI, 5.783–86.812; P < 0.001) for ≥3‐cm polyps compared with <1 cm polyps. In terms of operative modality, OR was 9.128 (95% CI, 3.548–23.486; P < 0.001) for EMR and 31.257 (95% CI, 7.009–139.395; P < 0.001) for ESD and 0.000 (P = 0.999) for forceps polypectomy compared with APC. Detailed information is listed in Tables 2 and 3.
Table 2

Analysis of risk factors for delayed postpolypectomy hemorrhage.

Uneventful (n = 1921)Hemorrhage (n = 41) P (two tailed)
Polyp location (%)0.855
Colon345/1921 (18.0)7/41 (17.1)
Left semicolon998/1921 (52.0)20/41 (48.8)
Right semicolon578/1921 (30.0)14/41 (34.1)
Polyp size (%)<0.001
<1 cm1561/1921 (81.3)19/41 (46.3)
1 cm ≤ polyp < 2 cm308/1921 (16.0)17/41 (41.5)
2 cm ≤ polyp < 3 cm41/1921 (2.1)2/41 (4.9)
≥3 cm11/1921 (0.6)3/41 (7.3)
Operative modality (%)<0.001
APC1094/1921 (56.9)5/41 (12.2)
EMR791/1921 (41.2)33/41 (80.5)
ESD20/1921 (1.1)3/41 (7.3)
Forceps polypectomy16/1921 (0.8)0/41 (0)
Pathology (%)<0.001
Hyperplastic + inflammatory polyp202/1921 (10.5)6/41 (14.6)
Tubular adenoma302/1921 (15.8)16/41 (39.0)
Villous adenoma18/1921 (0.9)3/41 (7.3)
Villous tubular adenoma106/1921 (5.5)7/41 (17.1)
Malignant tumor31/1921 (1.6)1/41 (2.4)
Serrated adenoma24/1921 (1.2)1/41 (2.4)
Juvenile polyp0 (0)1/41 (2.4)
Leiomyoma0 (0)1/41 (2.4)
Carcinoid1/1921 (0.05)0 (0)
Fibro‐epithelial hyperplasia2/1921 (0.1)0 (0)
No pathology1233/1921 (64.2)1/41 (12.2)
Bowel preparation (%)0.323
Excellent462/1921 (24.0)11/41 (26.8)
Good637/1921 (33.2)5/41 (22.0)
Fair724/1921 (37.7)17/41 (41.5)
Poor98/1921 (5.1)4/41 (9.7)
Specific operation experience (%)0.505
5–10 years22/1921 (1.1)0
10–15 years787/1921 (41.0)14/41 (34.1)
>15 years1112/1921 (57.9)27/41 (65.9)

APC, argon plasma coagulation; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.

Table 3

Regression analysis of risk factors for delayed postpolypectomy hemorrhage.

Odds ratio95% confidence interval P
Pathology
Hyperplastic/inflammatory polyp1
Adenomatous polyp1.8790.756–4.6690.174
Serrated adenoma1.4030.162–12.1500.759
malignant neoplasm1.0860.126–9.3280.940
Polyp size
<1 cm1
1–2 cm4.5352.331–8.823<0.001
2–3 cm4.0080.904–17.7760.068
>3 cm22.4075.783–86.812<0.001
Operative modality
APC1
EMR9.1283.548–23.486<0.001
ESD31.2577.009–139.395<0.001
Forceps polypectomy0ND0.999

APC, argon plasma coagulation; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.

Analysis of risk factors for delayed postpolypectomy hemorrhage. APC, argon plasma coagulation; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection. Regression analysis of risk factors for delayed postpolypectomy hemorrhage. APC, argon plasma coagulation; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.

Discussion

This study analyzed correlation factors for postpolypectomy hemorrhage. Delayed postpolypectomy hemorrhage occurred within the interval of 6 h to 4 days, at a mean time of 1.85 ± 1.05 days, which was similar to the findings of Kim Hee.13, 14 Therefore, more caution was needed against delayed hemorrhage 1–3 days after operation. Other studies reported the incidence of delayed hemorrhage within postoperative 6 h to 17 days.15 Therefore, postoperative surveillance for hemorrhage should be prolonged to avoid serious outcomes. Referring to prior literature, the present study also displayed polyp size as a conspicuous risk factor. Min and colleagues discovered that the incidence rate was 2.6‐fold higher for polyps larger than 1 cm than for smaller polyps.16 Another study reported that every 1‐mm increase in polyp size increased the incidence rate by 11.6%.17 Previous studies did not analyze the polyp size of various ranges but assessed the mean size. In contrast, the present study achieved a more meaningful conclusion by the classification of polyp size. Nonetheless, the limited number of >3‐cm polyps could give rise to bias. In terms of operative modality, Zhang et al. found that EMR or endoscopic piecemeal mucosal resection was more susceptible to hemorrhage compared with APC or biopsy forceps polypectomy, but without statistical significance.15 The present study demonstrated a 9.128‐fold incidence rate of hemorrhage in EMR and 31.257‐fold susceptibility to hemorrhage in ESD with statistical significance. The difference could be caused by the exclusion of ESD from the comparisons in Zhang's study. Regarding pathology, Watabe et al. believed that no difference in postoperative hemorrhage existed between adenoma and adenocarcinoma, with the conclusion derived from 37 cases.18 In contrast, Zhang and colleagues found a close correlation between pathology and postoperative hemorrhage (4.3‐ and 3.3‐fold), respectively, in juvenile polyposis and Peutz‐Jeghers syndrome compared with inflammatory/hyperplastic polyps.15 In the present study, no significant increase is found in hemorrhage in adenomatous polyps. Some studies suggested a correlation between polyp location and postpolypectomy hemorrhage. The right semicolon was more susceptible to postoperative hemorrhage compared with the left semicolon.19, 20 The present study detected no conspicuous correlation between them, which could be related to higher incidences of polyps in the left semicolon of Chinese populations but nearly equal incidence in the left and right semicolon of Western populations.21 In the present study, 17.9% of polyps were located in the rectum, 51.9% in the left semicolon, and 30.2% in the right semicolon. This study had certain limitations. First, it was a single‐center retrospective analysis, and data of only 1 year is not comprehensive. Second, the number of polyps ≥3 cm in size was inadequate, and hence, the results could interfere with the precision of the conclusion. Meanwhile, the assessment of bowel preparation was literally subjective, leading to potential bias on evaluation and hence a statistical error. In summary, this study demonstrated the risk factors for postpolypectomy hemorrhage, including polyp size and operative modality. For polyps >1 cm in size, the operative modality of ESD resulted in a higher incidence of hemorrhage. More clinical prudence should be taken in this regard.
  21 in total

1.  Efficacy of colonic submucosal saline solution injection for the reduction of iatrogenic thermal injury.

Authors:  Ian D Norton; Linan Wang; Susan A Levine; Lawrence J Burgart; Erik K Hofmeister; Ashwin Rumalla; Christopher J Gostout; Bret T Petersen
Journal:  Gastrointest Endosc       Date:  2002-07       Impact factor: 9.427

2.  Submucosal saline wheal as safety factor in fulguration or rectal and sigmoidal polypi.

Authors:  N ROSENBERG
Journal:  AMA Arch Surg       Date:  1955-01

3.  Risk assessment for delayed hemorrhagic complication of colonic polypectomy: polyp-related factors and patient-related factors.

Authors:  Hirotsugu Watabe; Yutaka Yamaji; Makoto Okamoto; Shintaro Kondo; Miki Ohta; Tsuneo Ikenoue; Jun Kato; Goichi Togo; Masayuki Matsumura; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastrointest Endosc       Date:  2006-07       Impact factor: 9.427

4.  Hemoclipping for postpolypectomy and postbiopsy colonic bleeding.

Authors:  A Parra-Blanco; N Kaminaga; T Kojima; Y Endo; N Uragami; N Okawa; T Hattori; H Takahashi; R Fujita
Journal:  Gastrointest Endosc       Date:  2000-01       Impact factor: 9.427

Review 5.  Epidemiology of colorectal polyps.

Authors:  A Giacosa; F Frascio; F Munizzi
Journal:  Tech Coloproctol       Date:  2004-12       Impact factor: 3.781

6.  Location in the right hemi-colon is an independent risk factor for delayed post-polypectomy hemorrhage: a multi-center case-control study.

Authors:  K Tim Buddingh; Thomas Herngreen; Jelle Haringsma; Wil C van der Zwet; Frank P Vleggaar; Ronald Breumelhof; Frank Ter Borg
Journal:  Am J Gastroenterol       Date:  2011-01-25       Impact factor: 10.864

7.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

Authors:  Ann G Zauber; Sidney J Winawer; Michael J O'Brien; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Benjamin F Hankey; Weiji Shi; John H Bond; Melvin Schapiro; Joel F Panish; Edward T Stewart; Jerome D Waye
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

8.  Asia Pacific consensus recommendations for colorectal cancer screening.

Authors:  J J Y Sung; J Y W Lau; G P Young; Y Sano; H M Chiu; J S Byeon; K G Yeoh; K L Goh; J Sollano; R Rerknimitr; T Matsuda; K C Wu; S Ng; S Y Leung; G Makharia; V H Chong; K Y Ho; D Brooks; D A Lieberman; F K L Chan
Journal:  Gut       Date:  2008-08       Impact factor: 23.059

9.  Colonoscopy: a prospective report of complications.

Authors:  J D Waye; B S Lewis; S Yessayan
Journal:  J Clin Gastroenterol       Date:  1992-12       Impact factor: 3.062

10.  Analysis of delayed postpolypectomy bleeding in a colorectal clinic.

Authors:  Do Hyoung Kim; Seok Won Lim
Journal:  J Korean Soc Coloproctol       Date:  2011-02-28
View more
  4 in total

1.  Prevention of delayed post-polypectomy bleeding by prophylactic clipping after endoscopic colorectal polypectomy: a meta-analysis.

Authors:  Zheng Yu; Eduardo Albéniz; Jing Hu; Peilin Li; Quan Li; Yaojun Hu; Jinpin Chen; Jinpeng Wang
Journal:  Int J Colorectal Dis       Date:  2022-09-29       Impact factor: 2.796

2.  Nomogram for the Prediction of Delayed Colorectal Post-Polypectomy Bleeding.

Authors:  Jiaping Huai; Xiaohua Ye; Jin Ding
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

Review 3.  Delayed Bleeding After Endoscopic Resection of Colorectal Polyps: Identifying High-Risk Patients.

Authors:  Oliver Bendall; Joel James; Katarzyna M Pawlak; Sauid Ishaq; J Andy Tau; Noriko Suzuki; Steven Bollipo; Keith Siau
Journal:  Clin Exp Gastroenterol       Date:  2021-12-24

4.  Endoscopic submucosal dissection vs endoscopic mucosal resection for colorectal polyps: A meta-analysis and meta-regression with single arm analysis.

Authors:  Xiong Chang Lim; Kameswara Rishi Yeshayahu Nistala; Cheng Han Ng; Snow Yunni Lin; Darren Jun Hao Tan; Khek-Yu Ho; Choon-Seng Chong; Mark Muthiah
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.